SEARCH OUR PRODUCT CATALOG

CCND1 FISH Probe

Our CCND1 probe is designed to detect CCND1 amplifications and deletions. The probe comes labeled in orange, but can be customized to meet your needs. 

Gene Background: Cyclin D1 (CCND1) regulates G1 to S-phase cell cycle transition alongside its binding partners, CDK4 and CDK6, via phosphorylation and inactivation of the retinoblastoma protein (pRb).1 First identified in 1991, CCND1 has been found amplified in about 9-30% of breast cancer cases.1 It’s also overexpressed in melanoma, mantle cell lymphoma, glioma, and endometrial, bladder, brain, esophageal, and colorectal cancer.2

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
CCND1-20-OR  (Standard Design) 20 (40 μL) 200 μL
CCND1-20-BIO 20 (40 μL) 200 μL
CCND1-20-RE 20 (40 μL) 200 μL
CCND1-20-DIG 20 (40 μL) 200 μL
CCND1-20-AQ 20 (40 μL) 200 μL
CCND1-20-GR 20 (40 μL) 200 μL
CCND1-20-GO 20 (40 μL) 200 μL

Gene Summary

The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. [provided by RefSeq, Jul 2008]

Gene Details

Gene Symbol: CCND1

Gene Name: Cyclin D1

Chromosome: CHR11: 69455872-69469242

Locus: 11q13.3

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.

Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure

Acral melanomas vary considerably in their molecular, histological, and clinical presentation. In this study, acral melanomas from dorsal, volar, and subungual-interdigital body sites were assessed using several tests, including FISH. Our TERT, CCND1, CDK4, AURKA, CDKN2A, PAK1, PTEN, NF1, and GAB2 probes were used to detect copy number variations in these genes. Genetic profiles were found to be tightly tied to UV exposure.

LobSig is a multigene predictor of outcome in invasive lobular carcinoma

Invasive lobular carcinoma (ILC) is a type of breast cancer defined by functional loss of E-cadherin, which results in cellular adhesion defects. This study sought to further characterize ILC’s genetic profile via analysis of 196 tumors. Using in silico integrative analyses, a 194-gene set – named ‘LobSig’ by the team – was identified, made up of genes frequently mutated in the tumor samples. LobSig was tested against the Nottingham Prognostic Index, PAM50 risk-of-recurrence (Prosigna), OncotypeDx, and Genomic Grade Index (MapQuantDx) for a 10-year follow-up period, and outperformed them all. As part of genetic profiling, Empire Genomics’ FGFR1 And CCND1 FISH probes were used to detect amplification of the genes.